Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity
出版年份 2016 全文链接
标题
Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity
作者
关键词
-
出版物
Scientific Reports
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-11-14
DOI
10.1038/srep36855
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Protective effect of resveratrol against chronic intermittent hypoxia-induced spatial memory deficits, hippocampal oxidative DNA damage and increased p47Phox NADPH oxidase expression in young rats
- (2016) Basel A. Abdel-Wahab et al. BEHAVIOURAL BRAIN RESEARCH
- Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation
- (2016) Ming Wu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 3,4-Dihydroxy-benzohydroxamic acid (Didox) suppresses pro-inflammatory profiles and oxidative stress in TLR4-activated RAW264.7 murine macrophages
- (2015) Thabe M. Matsebatlela et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6
- (2015) Hua Sun et al. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
- The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines
- (2015) Ghada A. Abdel-Latif et al. Scientific Reports
- P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
- (2015) Hossam M. Abdallah et al. Journal of Advanced Research
- Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression
- (2014) Zhen Liu et al. PLoS One
- The Efficacy of the Ribonucleotide Reductase Inhibitor Didox in Preclinical Models of AML
- (2014) Guerry J. Cook et al. PLoS One
- Resveratrol As Anti-Aging Therapy for Age-Related Bone Loss
- (2014) Isabel F. Tresguerres et al. REJUVENATION RESEARCH
- Cytotoxic activity of acyl phloroglucinols isolated from the leaves of Eucalyptus cinerea F. Muell. ex Benth. cultivated in Egypt
- (2014) Fathy M. Soliman et al. Scientific Reports
- Colon Cancer Therapy: Recent Developments in Nanomedicine to Improve the Efficacy of Conventional Chemotherapeutic Drugs
- (2013) J. Prados et al. Anti-Cancer Agents in Medicinal Chemistry
- Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase
- (2013) Lilian S. Gomez et al. BIOCHIMIE
- Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression
- (2013) P. Liu et al. Clinical & Translational Oncology
- Selective cytotoxic effects on human breast carcinoma of new methoxylated flavonoids from Euryops arabicus grown in Saudi Arabia
- (2013) Walied M. Alarif et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Didox potentiates the cytotoxic profile of doxorubicin and protects from its cardiotoxicity
- (2013) Ahmed M. Al-Abd et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dual role of resveratrol in modulation of genotoxicity induced by sodium arsenite via oxidative stress and apoptosis
- (2013) Chengzhi Chen et al. FOOD AND CHEMICAL TOXICOLOGY
- Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways
- (2013) MEIHONG ZHANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells
- (2013) ZHIYU ZHANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells
- (2013) Mai F. Tolba et al. IUBMB LIFE
- Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft
- (2013) Anil Mittal et al. PHYTOMEDICINE
- Resveratrol: A Natural Polyphenol with Multiple Chemopreventive Properties (Review)
- (2012) Fabrizia Brisdelli et al. CURRENT DRUG METABOLISM
- Cytotoxic ellagitannins from Reaumuria vermiculata
- (2012) Mahmoud A. Nawwar et al. FITOTERAPIA
- Chemopreventive effects of resveratrol and resveratrol derivatives
- (2011) Thomas Szekeres et al. Annals of the New York Academy of Sciences
- Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
- (2011) A. M. Al-Abd et al. CELL PROLIFERATION
- Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional Cancer Therapies
- (2011) Bettina M. Kaminski et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Anti-cancer characteristics of mevinolin against three different solid tumor cell lines was not solely p53-dependent
- (2011) Ali Mokhtar Mahmoud et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin
- (2010) Katharina Effenberger-Neidnicht et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Resveratrol, a Red Wine Polyphenol, Suppresses Pancreatic Cancer by Inhibiting Leukotriene A4 Hydrolase
- (2010) N. Oi et al. CANCER RESEARCH
- Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection
- (2009) Ru Zhou et al. BRITISH JOURNAL OF PHARMACOLOGY
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- Epigenetic mechanisms involved in differential MDR1mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy
- (2008) Tae-Bum Lee et al. BMC GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started